Published in J Neurochem on July 01, 2002
Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus. J Neurochem (2008) 1.32
Dynamic seizure-related changes in extracellular signal-regulated kinase activation in a mouse model of temporal lobe epilepsy. Neuroscience (2008) 1.04
Cell signaling underlying epileptic behavior. Front Behav Neurosci (2011) 0.96
Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS One (2011) 0.87
Activation of ERK by spontaneous seizures in neural progenitors of the dentate gyrus in a mouse model of epilepsy. Exp Neurol (2010) 0.86
Electrical, molecular and behavioral effects of interictal spiking in the rat. Neurobiol Dis (2012) 0.86
Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br J Pharmacol (2012) 0.86
Neuroanatomical clues to altered neuronal activity in epilepsy: from ultrastructure to signaling pathways of dentate granule cells. Epilepsia (2012) 0.84
Peroxisome proliferator-activated receptors γ/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus. J Neuroinflammation (2012) 0.84
Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis. Neurobiol Dis (2015) 0.80
N-methyl-D-aspartic acid receptor activation downregulates expression of δ subunit-containing GABAA receptors in cultured hippocampal neurons. Mol Pharmacol (2013) 0.78
Progressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in Neurons. Front Cell Neurosci (2016) 0.77
Pentylenetetrazol-induced epileptiform activity affects basal synaptic transmission and short-term plasticity in monosynaptic connections. PLoS One (2013) 0.77
Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations. J Neurophysiol (2014) 0.76
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures. Pharmacol Res Perspect (2014) 0.76
Involvement of BDNF/ERK signaling in spontaneous recovery from trimethyltin-induced hippocampal neurotoxicity in mice. Brain Res Bull (2016) 0.76
Hippocampal mitogen-activated protein kinase activation is associated with intermittent hypoxia in a rat model of obstructive sleep apnea syndrome. Mol Med Rep (2015) 0.75
Effects of valproate sodium on extracellular signal-regulated kinase 1/2 phosphorylation following hippocampal neuronal epileptiform discharge in rats. Exp Ther Med (2013) 0.75
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45
5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci (2011) 4.15
Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol (2004) 3.39
The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci (2006) 2.77
Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem (2006) 2.50
Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem (2004) 2.46
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J Neurosci (2008) 2.34
Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem (2003) 2.21
Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment. J Am Geriatr Soc (2013) 2.11
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration. J Neural Eng (2009) 1.80
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79
LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol (2006) 1.72
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem (2004) 1.58
RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem (2004) 1.57
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. J Neurosci (2009) 1.57
Rab11a and myosin Vb regulate recycling of the M4 muscarinic acetylcholine receptor. J Neurosci (2002) 1.54
Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci (2002) 1.53
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem (2011) 1.48
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Model prediction of anterior cruciate ligament force during drop-landings. Med Sci Sports Exerc (2004) 1.46
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol (2007) 1.45
Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci (2003) 1.45
An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A (2002) 1.43
Munc18 interacting proteins: ADP-ribosylation factor-dependent coat proteins that regulate the traffic of beta-Alzheimer's precursor protein. J Biol Chem (2003) 1.42
Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem (2005) 1.42
Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci (2008) 1.39
A comparison of forearm supination and elbow flexion strength in patients with long head of the biceps tenotomy or tenodesis. Arthroscopy (2010) 1.38
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res (2004) 1.35
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol (2010) 1.34
Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol (2002) 1.32
Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem (2002) 1.27
Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. J Proteome Res (2009) 1.27
Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord (2009) 1.19
Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics (2010) 1.16
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci (2007) 1.15
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci (2010) 1.14
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery. Mol Biol Cell (2008) 1.13
Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci (2008) 1.13
Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res (2008) 1.13
Chronically mad as a hatter: anticholinergics and Alzheimer's disease pathology. Ann Neurol (2003) 1.10
Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res (2010) 1.10
Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol (2002) 1.09
Mint3/X11gamma is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's Precursor protein from the trans-Golgi network. Mol Biol Cell (2007) 1.09
High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc (2013) 1.09
Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol (2011) 1.08
Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol (2006) 1.05
Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease. Alzheimer Dis Assoc Disord (2008) 1.05
Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. J Proteome Res (2012) 1.05
Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS One (2012) 1.05
Eye tracking during a visual paired comparison task as a predictor of early dementia. Am J Alzheimers Dis Other Demen (2009) 1.04
β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease. Neurotoxicology (2011) 1.03
Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo. J Neurosci (2010) 1.01
PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain. J Neuropathol Exp Neurol (2007) 0.99
Interaction of isoflurane with the dopamine transporter. Anesthesiology (2003) 0.99
Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease. J Comp Neurol (2007) 0.99
Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA alters amyloid-beta production. J Biol Chem (2010) 0.99
Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin Appl (2012) 0.98
Association of GSK3B with Alzheimer disease and frontotemporal dementia. Arch Neurol (2008) 0.98
Daytime sleepiness and functional impairment in Alzheimer disease. Am J Geriatr Psychiatry (2007) 0.97
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol Pharmacol (2003) 0.97
Neuron enriched nuclear proteome isolated from human brain. J Proteome Res (2013) 0.97
Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model. J Neurosci (2013) 0.96
Development of a rapid screening instrument for mild cognitive impairment and undiagnosed dementia. J Alzheimers Dis (2008) 0.96
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Neurology (2013) 0.95
Cell-specific extracellular signal-regulated kinase activation by multiple G protein-coupled receptor families in hippocampus. Mol Pharmacol (2003) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production. Mol Biol Cell (2012) 0.95
Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci (2008) 0.94
Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome. Methods Enzymol (2006) 0.94
Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci (2002) 0.94
The belly-press test for the physical examination of the subscapularis muscle: electromyographic validation and comparison to the lift-off test. J Shoulder Elbow Surg (2003) 0.93
Asparaginyl endopeptidase cleaves TDP-43 in brain. Proteomics (2012) 0.93
Proteomic analysis of postsynaptic density in Alzheimer's disease. Clin Chim Acta (2013) 0.92
Notch signaling inhibits PC12 cell neurite outgrowth via RBP-J-dependent and -independent mechanisms. Dev Neurosci (2002) 0.91
Rehabilitation exercise progression for the gluteus medius muscle with consideration for iliopsoas tendinitis: an in vivo electromyography study. Am J Sports Med (2011) 0.90
Mechanisms of compensating for anterior cruciate ligament deficiency during gait. Med Sci Sports Exerc (2004) 0.89
Fas-associated factor 1 and Parkinson's disease. Neurobiol Dis (2008) 0.88
Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation. ACS Chem Neurosci (2010) 0.87
Altered sleep regulation in a mouse model of SCN1A-derived genetic epilepsy with febrile seizures plus (GEFS+). Epilepsia (2013) 0.87
Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One (2013) 0.87
Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain. Neurosci Lett (2012) 0.87
Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurol (2007) 0.87
Elongation factor 1A family regulates the recycling of the M4 muscarinic acetylcholine receptor. Neurochem Res (2006) 0.87
Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling. J Neuroinflammation (2012) 0.86
Condition HELP: a pediatric rapid response team triggered by patients and parents. J Healthc Qual (2008) 0.86
Novel interaction between the M4 muscarinic acetylcholine receptor and elongation factor 1A2. J Biol Chem (2002) 0.85
RNF11 modulates microglia activation through NF-κB signalling cascade. Neurosci Lett (2012) 0.85
Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history. Neurogenetics (2007) 0.84
Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease. Dement Geriatr Cogn Disord (2008) 0.84
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol (2015) 0.84
Breathing and sleep: measurement methods, genetic influences, and developmental impacts. ILAR J (2009) 0.84
Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration. Mol Neurodegener (2011) 0.84